A Safety and Efficacy Study of Doxil and Taxotere +/- Herceptin in Advanced Breast Cancer
Phase of Trial: Phase II
Latest Information Update: 20 Aug 2013
At a glance
- Drugs Trastuzumab (Primary) ; Docetaxel; Doxorubicin liposomal
- Indications Advanced breast cancer
- Focus Adverse reactions; Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 02 Jun 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 26 Sep 2005 New trial record.